Cerevel Therapeutics Holdings Inc (CERE)
42.10
+0.20
(+0.48%)
USD |
NASDAQ |
Apr 25, 16:00
42.10
0.00 (0.00%)
After-Hours: 20:00
Cerevel Therapeutics Holdings Shareholders Equity (Quarterly): 673.74M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 673.74M |
| September 30, 2023 | 272.96M |
| June 30, 2023 | 350.50M |
| March 31, 2023 | 431.71M |
| December 31, 2022 | 521.24M |
| September 30, 2022 | 603.36M |
| June 30, 2022 | 452.81M |
| Date | Value |
|---|---|
| March 31, 2022 | 521.50M |
| December 31, 2021 | 578.73M |
| September 30, 2021 | 629.08M |
| June 30, 2021 | 293.89M |
| March 31, 2021 | 340.04M |
| December 31, 2020 | 384.52M |
| September 30, 2020 | 142.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
142.59M
Minimum
Sep 2020
673.74M
Maximum
Dec 2023
442.62M
Average
442.26M
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie Inc | 10.36B |
| Immunogen Inc (DELISTED) | 561.60M |
| Bristol-Myers Squibb Co | 29.43B |
| Science 37 Holdings Inc (DELISTED) | 51.74M |
| Madrigal Pharmaceuticals Inc | 405.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.243B |
| Total Liabilities (Quarterly) | 569.55M |